Analyst Research: Synta Pharmaceuticals Corp (SNTA.OQ)

SNTA.OQ on NASDAQ Stock Exchange Global Market

2.38USD
2 Mar 2015
Change (% chg)

$-0.02 (-0.83%)
Prev Close
$2.40
Open
$2.40
Day's High
$2.45
Day's Low
$2.37
Volume
130,992
Avg. Vol
280,036
52-wk High
$6.60
52-wk Low
$2.18

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - SYNTA PHARMACEUTICALS CORP (SNTA-O) 2 Mar 2015 Thomson Reuters Stock Report 11 25.00
ValuEngine Rating and Forecast Report for SNTA 1 Mar 2015 ValuEngine, Inc. 11 25.00
Synta Pharmaceuticals 28 Feb 2015 S&P Capital IQ Quantitative Report 11 127.00
Synta Pharmaceuticals Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 27 Feb 2015 Reuters Investment Profile 12 20.00
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of SYNTA PHARMACEUTICALS CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 26 Feb 2015 Jefferson Research 11 20.00
ValuEngine Industry Report for Medical-biomed/genetics(SNTA) 24 Feb 2015 ValuEngine, Inc. 10 49.00
SYNTA PHARMACT (SNTA) Zacks Company Snapshot 24 Feb 2015 Zacks Investment Research Inc. 1 12.00
Value Graph: SYNTA PHARMACEUT -- SNTA 19 Feb 2015 Ford Investor Services, Inc. 1 12.00
SYNTA PHARMACT (SNTA) Zacks Company Snapshot 9 Feb 2015 Zacks Investment Research Inc. 1 12.00
SYNTA PHARMACT (SNTA) Zacks Company Snapshot 5 Feb 2015 Zacks Investment Research Inc. 1 12.00
 
Name Age Since Current Position

Keith Gollust

68 2014 Chairman of the Board

Anne Whitaker

47 2014 President, Chief Executive Officer, Director

Marc Schneebaum

60 2014 Chief Financial Officer, Senior Vice President

Chen Schor

42 2014 Chief Operating Officer, Executive Vice President

Arthur McMahon

68 2014 Senior Vice President - People Operations
Search Stocks